Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Old article but highlights Baltia (BLTA) and it's continued failures leading to this point. BLTA is a stock that was traded mainly by insiders for god knows what reasons at the expense of the investors.
http://www.traveller.com.au/baltia-airlines-to-rebrand-as-usglobal-may-fly-first-passengers-in-its-27year-history-gxi0w7
I guess in the case of DuFort (IDGC), a broken clock is right twice a day. But this week, next week, next month, next quarter and next year all have been stated dating back to February 2013. IJS
If/when the earnings for ANTH comes out on May 8th and they're decent, there should definitely be a move upward, IMO of course. I'm hoping for good news and a even better run north.
kazorchian, IDGC is in a slumber right now but should awaken later in the year. DuFort (IDGC) will pull something out of his four-point-of-contact to do a pump and there will be an influx of people promoting the stock on this board. If history repeats itself, with the pump you'll see a volume increase, followed by a PPS increase that will bounce between $0.0002 and $0.0003.
If you got in at $0.0001, sell at these price points because it won't get any higher. Then buy back in when IDGC falls back to $0.0001 and wait it out until the next pump. I've done this over the past 2 years and will again this year after holding "LONG" for just over 2 years prior to just trading IDGC.
This information on ANTH was pulled from Zack's and they've listed it as a "HOLD". This wasn't written by me, just posted to the ANTH board for all to know.
Zacks Investment Research, Inc. downgrades ANTHERA PHARMACEUTICALS INC from BUY to HOLD.
BY Investars Analyst Actions - private — 7:22 AM ET 04/26/2018
On April 26, 2018 Zacks Investment Research, Inc. downgraded ANTHERA PHARMACEUTICALS INC (ANTH) from BUY to HOLD.
Analyst Recommendations for: EV Energy Partners LP (EVEP)
By Jodi Jackson - April 30, 2018013
Trading Statistics: https://theriponadvance.com/analyst-recommendations-for-ev-energy-partners-lp-evep/121186000/
EV Energy Partners LP (EVEP) ended its last session at $0.13 by Declining -2.88%. The company currently has an average volume of 1.34 Million. EV Energy Partners LP has its outstanding Shares of 51.85 Million.
Market capitalization is the total market value of all of a company’s outstanding shares. Market capitalization is calculated by multiplying a company’s shares outstanding by the current market price of one share. The investment community uses this figure to determine a company’s size, as opposed to sales or total asset figures. EV Energy Partners LP (EVEP) has the market capitalization of 6.99 Million.
The (Simple Month Average) SMA20 is at -15.26 percent, its SMA50 Value is -59.77% and SMA200 value is reported as -75.46 Percent. The stock is currently showing its Return on Assets (ROA) value of -8.8 Percent. The Return on Equity (ROE) and Return on Investment values are -19 percent and -9.4 percent respectively.
EV Energy Partners LP (EVEP) has an annual dividend of $0, while its annual dividend yield is 0%. A dividend is a distribution of a portion of a company’s earnings decided by its BOD (board of directors) specifically for its shareholders. Dividends are mostly given in terms of cash payments, property or as shares of stock.
If we look at the Volatility of the company, Week Volatility is 6.33%, whereas Month Volatility is at 1.70%. The ATR (Average True Range) value is 0.02.
Year to date (YTD) refers to the period beginning the first day of the current calendar or fiscal year up to the current date. YTD information is useful for analyzing business trends or comparing performance data, and the acronym often modifies concepts such as investment returns, earnings and net pay. Year to Date (YTD) performance of EV Energy Partners LP (EVEP) is -73.55 percent while its Performance (Week) is -9.34 percent and Performance (month) is at -15.69 percent.
Ha! You're definitely right about " they are not a reporting company" for dang sure. I'm hopeful that DuFort (IDGC) will pull something out of his hind-parts on another pump. I'm not convinced there is "a new management team" at this point. We'll more than likely be here this time next year repeating the same assertions from both perspectives like the last 5 years.
Ducktor, "I think there will be major announcement coming any day now by the new management team"? Really? This has been the same song now for years. Also, what new management team. I think that I must have missed the change of ownership filings for IDGC.
I agree with you 100% money6870, DuFort is truly a cancer for this ticker but I doubt that he would want to give up his only means of cash flow. He's used this ticker like a ATM over the past 5 years with his pumps. But I think all are now hip to his shenanigans.
I take it that people are now understanding that nothing that DuFort (IDGC) can be believed or trusted? The silence has become deafening to say the least when it comes to this con-man (DuFort). Unfortunately I don't think that he can pull another "pump" out of his four-point-of-contact to get this thing moving seeing that his failed dividend offer didn't work this time like before.
Those who choose to blindly believe in DuFort and claim to know that there are things "in the work" have been saying this for years now. It's always the next week, the next month, the next quarter the next year and so on and so forth. IDGC has no products, no distribution lines, no revenue, no employees, no leadership and most important absolutely no credibility at this point.
Hope for a successful pump and get out when you can on this one folks.
HOLLYWOOD MEDIA (HOLL) Shorts Up By 62.5%
April 18, 2018 - By Winifred Garcia
HOLLYWOOD MEDIA CORP (OTCMKTS:HOLL) had an increase of 62.5% in short interest. HOLL’s SI was 1,300 shares in April as released by FINRA. Its up 62.5% from 800 shares previously. It closed at $0.225 lastly. It is down 0.00% since April 18, 2017 and is . It has underperformed by 11.55% the S&P500.
Analysts expect MGM Growth Properties LLC (NYSE:MGP) to report $0.52 EPS on April, 26 before the open.They anticipate $0.03 EPS change or 6.12% from last quarter’s $0.49 EPS. MGP’s profit would be $138.34M giving it 13.53 P/E if the $0.52 EPS is correct. After having $0.52 EPS previously, MGM Growth Properties LLC’s analysts see 0.00% EPS growth. The stock increased 1.77% or $0.49 during the last trading session, reaching $28.15. About 1.27 million shares traded or 50.45% up from the average. MGM Growth Properties LLC (NYSE:MGP) has risen 0.27% since April 18, 2017 and is uptrending. It has underperformed by 11.28% the S&P500.
Hollywood Media Corp. provides advertising services. The company has market cap of $5.09 million. It operates through Ad Sales and Intellectual Property divisions. It has a 0.82 P/E ratio. The Ad Sales division operates MovieTickets.com that allows users to purchase movie tickets and retrieve them at will call windows or kiosks at theaters.
MGM Growth Properties LLC engages in owning, acquiring, and leasing casino resort properties in the United States. The company has market cap of $7.49 billion. It resorts provide casino gaming, hotel, convention, dining, entertainment, retail, and other resort amenities. It has a 42.01 P/E ratio. As of December 31, 2016, the company??s properties include approximately 27,233 hotel rooms, 2.6 million square feet of convention space, 100 retail outlets, 200 food and beverage outlets, and 20 entertainment venues.
Among 6 analysts covering MGM Growth Properties (NYSE:MGP), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. MGM Growth Properties had 6 analyst reports since May 16, 2016 according to SRatingsIntel. The stock of MGM Growth Properties LLC (NYSE:MGP) has “Buy” rating given on Tuesday, November 22 by Buckingham Research. As per Monday, May 16, the company rating was initiated by Citigroup. The stock of MGM Growth Properties LLC (NYSE:MGP) earned “Buy” rating by Suntrust Robinson on Monday, May 16. Morgan Stanley initiated the stock with “Overweight” rating in Monday, May 16 report. As per Monday, May 16, the company rating was initiated by JP Morgan. Deutsche Bank initiated MGM Growth Properties LLC (NYSE:MGP) on Monday, May 16 with “Buy” rating.
Source: https://flintdaily.com/mgm-growth-properties-mgp-analysts-see-0-52-eps-hollywood-media-holl-shorts-up-by-62-5/
Surprising Stocks – Anthera Pharmaceuticals, Inc., NASDAQ: ANTH)
By DNN TEAM - April 20, 2018
Anthera Pharmaceuticals, Inc.
The Healthcare stock (Anthera Pharmaceuticals, Inc.) showed a change of 0.38 percent from opening and finally turned off its business at $0.34 by scoring 2.99 percent on 19-04-2018. Anthera Pharmaceuticals, Inc., belongs to Healthcare sector and Biotechnology industry.
Historical Performance Review: To understand the smudge picture investors will must to look a little deeper. The Anthera Pharmaceuticals, Inc. has shown a five days performance of -3.21% and thirty days performance stands at 3.62%. The stock has shown a ninety days performance of -73.57% and a six months performance stands at -77.86%.
Market Capitalization/Outstanding Shares/Intraday Volume: The company’s Market capitalization is $7.99M with the total Outstanding Shares of 23.43M. Market capitalization refers to the entire dollar market cost of a company’s outstanding shares. Referred to as “market cap,” it is determined by doubling a company’s shares outstanding by the current market price of one share. Outstanding shares refer to a company’s stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s officers and insiders.
The Anthera Pharmaceuticals, Inc. exchanged hands with 1392735 shares compared to its average daily volume of 3.03M shares. Total volume is the number of shares or deals that point towards the overall activity of a security or market for a given period. Volume is an important indicator in technical analysis as it is used to measure the relative worth of a market move. If the markets make a firm price movement, then the strength of that movement depends on the volume for that period. The higher the volume during the price move, the more significant the progress.
Institutional Ownership/ Insider Ownership: Anthera Pharmaceuticals, Inc. institutional ownership is held at 26.5% while insider ownership was 1.78%. Institutional ownership refers to the ownership stake in a company that is held by large financial organizations, pension funds or endowments. Institutions purchase large blocks of a company’s outstanding shares and can exert considerable influence upon its management.
P/S, P/E, P/C and P/B/ SMA50, SMA 200: The price-to-sales is a valuation ratio that relates a company’s stock price to its revenues. The price-to-sales ratio is a symbol of the value placed on each dollar of a company’s sales or taxes. As of now, ANTH has a P/S, P/E and P/B values of 0, 0 and 0 respectively. P/E and P/B ratios both are used on a regular basis by the investor to measure the value of the company and to get the right amount of the share.
Its P/Cash valued at 3.63. The price-to-cash-flow ratio is a stock valuation indicator that measures the value of a stock’s price to its cash flow per share
The stock has observed its SMA50 which is now -70.47%. In looking the SMA 200, we see that the stock has seen an -76.75%.The Company’s net profit margin for the 12-months at 0%. Comparatively, the company has a Gross margin 0%.
Profitability Ratios (ROE, ROA, ROI): Looking into the profitability ratios of ANTH stock, an investor will find its ROE, ROA, ROI standing at 0%, -234.4% and 0%, respectively. Return on assets (ROA) is a financial ratio that shows the percentage of profit a company earns about its overall resources. A performance measure used to estimate the efficiency of an investment or to compare the ability of some different investments. ROI measures the amount of return on an investment relative to the investment’s cost.
Earnings per Share Details of Anthera Pharmaceuticals, Inc.: The EPS of ANTH is strolling at -3.31, measuring its EPS growth this year at 77.8%. As a result, the company has Earnings per Share (EPS) growth of 18.7% for the coming year. Given the importance of identifying companies that will ensure earnings per share at a high rate, we later obsession to umpire how to determine which companies will achieve high amassing standards. One obvious showing off to identify high earnings per portion count together companies are to locate companies that have demonstrated such build up beyond the p.s. 5 to 10 years. We can’t have enough maintenance the once will always reflect the difficult, but logically stocks that have grown earnings per allowance sharply in the after are an excellent bet to continue to take effect as a result.
Target Price/Analysts Mean Suggestion: Mostly, a price target is an individual analyst’s expectation on the future price of a security, usually a stock. There may be many price targets for only protection. Analyst’s mean target cost for the company is $6.5 while analysts mean suggestion is 2.
Beta/Volatility: A beta factor is used to measure the volatility of the stock. A Beta component of the stock stands at 2.77. Beta element is utilized to gauge the unpredictability of the stock. The stock remained 5.66% volatile for the week and 9.86% for the month.
Source: https://www.dailynysenews.com/surprising-stocks-anthera-pharmaceuticals-inc-nasdaq-anth-valvoline-inc-nyse-vvv/
Money6870, sadly I think that you're correct. DuFort has been nothing but a failure on ever endeavor that he has tried. Nothing has materialized from any of the PR's that he's put out since 2014 and the lies are plentiful.
Hope for spikes to $0.0002 or $0.0003 for those who got in at $0.0001 so that they can break even or make a little profit and then run for the hills away from $IDGC.
I have my jeopardy music playing softly in the background waiting for $ANTH to make some type of upward move....
I have my jeopardy music playing for $EVEP now.
$HOLL is down down 8% since I bought in, not looking good at this point.
Money6870, DuFort is and always has been a con-man. There are way too many people who actually believe anything this guy says.
Thanks love your neighbor, I'm not exactly sure what was going on but my order finally got filled through eTrade and I cancelled the other 2. I have never seen anything like that before. Just a bit odd to me.
Mymonies, I agree with you and love your neighbor, but I have 1 major problem. I can't get a buy in at $0.23 from eTrade, Fidelity or TD Ameritrade. I have a purchase in for the 2500 shares out there for $0.23 but no buy. WTH??
Everyone should have known that the free dividend disbursement was nothing more than an attempt to draw in new investors. Unlike the first dividend promise (PUMP) this one failed miserably. DuFort (IDGC) has repeated his history of BS'ing us (investors/shareholders) and their are too many people tossing unsubstantiated rumors around for no apparent reason. There are no filings at all to say that DuFort is out but yet a select few speculate that he is. Wheres the proof? Did I miss a IDGC filing stating as much? All of us just need to sit back and wait for the next pump attempt to see if you can either get out or make a little coinage if you got in at $0.0001.
I like many other shareholders/investors are hoping that you're right, but skepticism is abundant for most at this point.
ducktor, I thought that March was going to be IDGC's breakout month? Or was it February? Maybe it was January? This pattern can be easily tracked back to February 2012.
WallStreetMyWay, you're correct in your post and I 100% agree with you on transparency into what the company's plan is going forward. But unfortunately that hasn't been a strong point in IDGC's history. Maybe, there will be a change within IDGC where they stop repeating the past, maybe not. But until then speculation rules here about the direction IDGC is going.
Well folks I can see that $IDGC is continuing it's history of false promises that too many are overly optimistic by posting false speculation of business operations. Unrealistic expectations of IDGC have been flowing like the mighty Mississippi River for the past year that has resulted in nothing more than extreme disappointment for those who believed the hype.
LMAO!!!! Ok, you feel free to believe that.
PR's been good? When has anything from the PR's been completed? Ever? I'm not seeing anything...yet.
Mick, I will not be holding my breath on this. I'll simply have to wait and see it to believe it like all other shareholders/investors. Until then everything is speculation and/or conjecture when it come s to $IDGC and whats "actually" going on.
Speculation and IDGC go hand-in-hand. Unfortunately starting to speculate on a name change that can't be substantiated at this time is nothing more than a waste of time.
Our CEO isn't much of of a CEO and changing the name of the company would do nothing to bolster shareholder confidence nor bring in new buyers. We need tangible products with distribution lines already laid out for the products that were promised just recently.
Remember, DuForts (IDGC) latest pump attempt on promising a dividend didn't do a thing. I guess he forget that he told this same lie a little over a year ago. Nobody bought into it this time, maybe his next pump attempt will be well received by all.
Same here, I hopped into $EVEP at $0.135 and hoping for a good bounce up in a couple weeks. So far so good so we'll see, I've got my fingers crossed on this one. :)
I've seen that a few times over the past 4 weeks, lol. I thought that I was the only one who noticed, lmao.
Lmao, lmao
money6870, I believe about 2 or 3 years ago DuFort (IDGC) was attempting to get in the RTD market with a MJ (cannabis) infused product (he failed miserably) and changed IDGC's sector to cannabis.
Kmacneill116, I hope that your overly optimistic speculation on "news coming soon" comes to fruition. Seeing that the most recent news from DuFort (IDGC) has bore no fruit for PPS growth at all.
Another IDGC week of overly optimistic speculations which created unrealistic expectations resulting in extreme disappointment for investor/shareholders once again. On to the next week....
I've honestly been trying to figure out how they'll pull this dividend handout for the past 2 weeks. I have nothing, no clue on how they'll make this work. I think this was nothing more than a pump to get more investors in that fell flat. Maybe in the October-September time frame they'll be able to orchestrate a better pump for us.
LA4321 you're correct on the dividends. It's unlikely that they'll materialize which is nothing more than a carbon copy from the last time IDGC shockholders were supposed to receive one. I'm not optimistic on getting them but if it comes through I'll be more than surprised. Remember that DuFort (IDGC) gave no time-frame of which these "dividends" will be dispersed to IDGC shockholders.
Lmao, I know the feeling. I held IDGC for just over 2 years before I started trading the trends and now I'm playing with a lot of free shares now.
audioguy, you'll only be able to sell at IDGC $0.0002 when volume spikes and there are $0.0002's on the bid not just the ask. This happens maybe once a year. You just have to be ready for it when it does.